Metabolic reprogramming has emerged as a crucial regulator of immune cell activation, but how systemic metabolism influences immune cell metabolism and function remains to be investigated. To investigate the effect of dyslipidemia on immune cell metabolism, we performed in-depth transcriptional, metabolic, and functional characterization of macrophages isolated from hypercholesterolemic mice. Systemic metabolic changes in such mice alter cellular macrophage metabolism and attenuate inflammatory macrophage responses. In addition to diminished maximal mitochondrial respiration, hypercholesterolemia reduces the LPS-mediated induction of the pentose phosphate pathway (PPP) and the Nrf2-mediated oxidative stress response. Our observation that suppression of the PPP diminishes LPS-induced cytokine secretion supports the notion that this pathway contributes to inflammatory macrophage responses. Overall, this study reveals that systemic and cellular metabolism are strongly interconnected, together dictating macrophage phenotype and function.
In Brief
The link between systemic and cellular metabolism is a neglected aspect in immunometabolism. Baardman et al. show that hypercholesterolemia alters macrophage metabolism and phenotype. The suppressed pentose phosphate pathway (PPP) in those ''foam cell'' macrophages attenuates inflammatory responses, signifying that systemic and cellular metabolism together regulate macrophage function.
INTRODUCTION
In recent years, metabolic reprogramming arose as a crucial controller of macrophage activation (Van den Bossche et al., 2016 Bossche et al., , 2017 . For instance, in response to pro-inflammatory stimuli such as the Toll-like receptor 4 (TLR4) ligand lipopolysaccharide (LPS), macrophages show increased glycolysis, as demonstrated by an enhanced extracellular acidification rate (ECAR) (Van den Bossche et al., 2016) . Moreover, LPS reconfigures the tricarboxylic acid (TCA) cycle in macrophages and induces itaconate and succinate accumulation (Jha et al., 2015; Tannahill et al., 2013) . Itaconate is a key controller of inflammatory macrophage responses through its regulatory effect on succinate dehydrogenase and its activation of the anti-oxidant transcription factor Nrf2 (Lampropoulou et al., 2016; Michelucci et al., 2013; Mills et al., 2018) . Succinate promotes inflammation by inducing interleukin 1b (IL-1b) expression (Mills et al., 2016; Tannahill et al., 2013) and can activate immune cells in the local environment upon secretion (Littlewood-Evans et al., 2016) . Furthermore, the activity of the pentose phosphate pathway (PPP) is enhanced in LPS-stimulated macrophages, supplying precursors for nucleotide synthesis and nicotinamide adenine dinucleotide phosphate (NADPH), which is used for reactive oxygen species (ROS) production by NADPH oxidase, fatty acid synthesis, and anti-oxidant cellular defense (Nagy and Haschemi, 2015; Wu et al., 2008) . So far, most knowledge regarding macrophage immunometabolism was obtained with in vitro-cultured bone marrow-derived macrophages and largely ignored the possible systemic and micro-environmental effects on macrophage metabolism and function in vivo (Norata et al., 2015) . Exploring this neglected aspect of immunometabolism might identify therapeutic strategies to dampen chronic inflammatory diseases such as atherosclerosis, in which lipid-laden macrophage ''foam cells'' are crucial during all stages of the disease. Elevated levels of circulating low-density lipoprotein (LDL) cholesterol, as observed in patients with familial hypercholesterolemia (FH), are a prominent risk factor for developing atherosclerosis (Ference et al., 2017) . FH is predominantly caused by loss-of-function mutations in the LDL receptor (LDLR) gene, leading to impaired hepatic uptake of LDL and, consequently, elevated levels of plasma LDL (Reiner, 2015) . It has been shown that hypercholesterolemia affects the lipidome of macrophages and deactivates part of their inflammatory responses via activation of LXR (Spann et al., 2012) . However, LXR-independent repression mechanisms still need to be defined. Here we confirm that hypercholesterolemia attenuates LPS-induced inflammatory macrophage responses and show that this deactivated phenotype is accompanied by a diminished Nrf2-mediated oxidative stress response and LXR-independent suppression of the PPP, indicating that systemic and cellular metabolism are directly intertwined, together regulating macrophage function.
RESULTS

Hypercholesterolemia Translates into Altered Immune Cell Metabolism
Ingenuity Pathway Analysis (IPA) of published FH patient microarray data (GEO: GSE13985; characteristics in Table S1 ) identified oxidative phosphorylation (OXPHOS) and mitochondrial dysfunction among the top-ranked enriched canonical pathways ( Figure 1A ), and most differentially expressed genes belonging to those pathways were downregulated in leukocytes of FH patients ( Figure 1B) .
To study the effects of systemic metabolic changes on immune cell metabolism in more detail, Ldlr ko mice were fed a high-fat diet (HFD) to induce hypercholesterolemia and hypertriglyceridemia or a normal-fat control diet (NFD) (Figures S1A-S1C). Peritoneal macrophages from HFD mice were elicited as a validated in vivo model and source of foam cells (Spann et al., 2012) . CD11b + F4/80 + peritoneal macrophages isolated from the HFD group were lipid-laden foam cells (hereafter referred to as ''HFD macrophages''; Figures S1D and S1E) and compared with ''NFD macrophages'' to evaluate the effect of systemic metabolism on macrophage metabolism independent of microenvironmental cues present in atherosclerotic lesions.
To study the effects of these different lipid environments on glycolysis and mitochondrial function in macrophages, we performed an extracellular flux analysis and revealed similar basal glycolysis and mitochondrial respiration in macrophages isolated from mice fed either diet ( Figure 1C) . Interestingly, HFD macrophages demonstrated lower maximal mitochondrial respiration and a reduced spare respiratory capacity (SRC) ( Figure 1D ) but showed no differences in non-mitochondrial oxygen consumption, ATP production, and proton leak ( Figure S2A ). Furthermore, both macrophage types showed similar fuel dependencies, with fatty acids being the main drivers of mitochondrial oxygen consumption ( Figure 1E ). Because reduced mitochondrial mass results in decreased SRC in T cells (van der Windt et al., 2012) , we assessed whether a lower mitochondrial abundance could explain the reduced SRC in HFD macrophages. Supporting this notion, HFD macrophages indeed showed a lower mitochondrial mass, as demonstrated by MitoTracker Green staining, mitochondrial DNA:genomic DNA ratio, and mitochondrial complex immunoblotting (Figures 1F and 1G and S2B) . Together with the observation that similar amounts of mitochondria isolated from NFD or HFD macrophages display equal respiration ( Figure 1H ), our data strongly suggest that the reduced maximal respiration in HFD macrophages is mainly due to a decrease in mitochondrial mass. RNA sequencing revealed that genes related to mitochondrial biogenesis and dynamics were not altered in HFD macrophages; this was further confirmed by qPCR and immunoblotting ( Figures S2C-S2E ). Pathway analysis indicated that the top most enriched pathways were related to cholesterol biosynthesis, and associated genes were downregulated in HFD macrophages ( Figures 1I and 1J) .
Given the importance of metabolites such as itaconate, succinate, and a-ketoglutarate in regulating macrophage function (Lampropoulou et al., 2016; Liu et al., 2017; Michelucci et al., 2013; Mills et al., 2016 Mills et al., , 2018 Tannahill et al., 2013) , we next measured the levels of an extensive set of 63 metabolites. Partial least square discriminant (PLS-DA) analysis was used to discriminate NFD and HFD macrophages based on the measured metabolites. Interestingly, the abundance of several metabolites varied among NFD and HFD macrophages, with itaconate as the most distinctive metabolite ( Figure 1K ), whose abundance was lower in HFD macrophages (Table S2) . Overall, hypercholesterolemia is associated with reduced mitochondrial mass and maximal respiration and affects the levels of metabolites such as itaconate. 
Hypercholesterolemia Attenuates Inflammatory Macrophage Responses without Major Changes in
Glycolysis or the TCA Cycle Because itaconate regulates inflammatory macrophage responses (Jha et al., 2015; Mills et al., 2018) and was reduced in naive HFD macrophages, we investigated the effects of hypercholesterolemia on LPS-induced inflammatory macrophage activation. In parallel to the previously reported decreased expression of several inflammatory genes, we identified reduced secretion of pro-inflammatory cytokines as well as lower nitric oxide (NO) and lower ROS levels in HFD macrophages ( Figures  2A-2C ). Both types of macrophages exhibited similar phagocytic activity and comparable expression of Il10 and IL-4-induced genes and surface proteins ( Figures 2D, S3A , and S3B). Together, this does not indicate a general inhibition of macrophage activation in the HFD group but shows that these cells undergo a deactivation process during which foam cells lose part of their LPS-induced inflammatory properties. Likewise, short exposure to oxidized or acetylated LDL in vitro also decreased subsequent LPS-induced tumor necrosis factor (TNF), IL-6, and NO secretion in NFD macrophages ( Figure S3C ).
To address whether distinct LPS-induced metabolic rewiring underlies the deactivated phenotype of HFD foam cells, we measured glycolysis upon acute and 24-hr LPS exposure. NFD and HFD macrophages showed comparable glycolytic rates and glucose uptake ( Figure 2E , 2F, and S3D), indicating that the attenuated inflammatory phenotype of HFD macrophages is probably not caused by reduced glycolysis.
Next we examined whether differences in succinate, itaconate, a-ketoglutarate, or other metabolites could explain the attenuated pro-inflammatory function of LPS-stimulated HFD macrophages. PLS-DA identified distinct metabolic profiles upon LPS stimulation in macrophages from both groups (Figure 2G) . We observed that LPS induced itaconate, succinate, and oxaloacetate levels to a similar extent in both NFD and HFD macrophages ( Figure 2H ). This suggests that the reduced inflammatory phenotype observed in HFD macrophages is not caused by a distinct LPS-induced TCA cycle reconfiguration. In addition to altered levels of different amino acids (Figures 2I) and increased levels of NADH in HFD macrophages (Table S2) , several metabolites related to the PPP (marked with asterisks in Figure 2I ) strongly contributed to the differential metabolic profile in LPS-stimulated NFD and HFD macrophages.
Hypercholesterolemia Diminishes the NRF2 and PPP in Macrophages
Metabolic analysis demonstrated an increased abundance of several PPP metabolites, including ribose-5P or ribulose-5P, sedoheptulose-7P, and glyceraldehyde 3-P upon LPS stimulation ( Figure 3A) . Interestingly, LPS-induced ribose-5P or ribulose-5P and sedoheptulose-7P levels were lower in HFD macrophages. Analyzing the two genes that encode glucose-6-phosphate dehydrogenase (G6PD) as the rate-limiting enzyme of the PPP in mice (Huminiecki and Wolfe, 2004) revealed that the LPS-induced elevation of G6pd2, but not G6pdx, was absent in HFD macrophages ( Figures 3B and 3C) . Moreover, Pgd (encoding 6-phosphogluconate dehydrogenase, which converts 6-phosphogluconate into ribulose 5-P in the PPP) was reduced in both naive and LPS-stimulated HFD macrophages ( Figure 3B ), whereas Pgd protein levels were only suppressed in naive HFD macrophages ( Figure S4A ). To validate whether suppression of the PPP in HFD macrophages ( Figure 3D ) could explain their attenuated LPS-induced inflammatory responses, we pharmacologically inhibited G6PD with dehydroepiandrosterone (DHEA) or 6-aminonicotinamide (6-AN). Supporting this notion, blockade of the PPP diminished the LPS-induced production of pro-inflammatory mediators in macrophages ( Figure 3E ). Because desmosterol-driven LXR activation regulates at least a part of the inflammatory phenotype of foam cells (Spann et al., 2012) , we studied whether this pathway controls the PPP. Activation of LXR and its target genes with GW3965 did not affect PPP genes and metabolites ( Figures S4B-S4D ), backing the idea that both LXR-dependent and independent mechanisms contribute to the diminished inflammatory phenotype of foam cells (Spann et al., 2012) .
To uncover the LXR-independent mechanistic link between hypercholesterolemia, suppressed PPP, and inflammation, we further explored our RNA sequencing (RNA-seq) dataset. Pathways analysis revealed that the Nrf2 pathway was the most differentially regulated pathway between LPS-stimulated NFD and HFD macrophages ( Figure 3F ), and most genes of this pathway were downregulated in HFD macrophages ( Figure 3G ). Accordingly, Nrf2 protein levels were reduced in LPS-treated HFD macrophages ( Figure 3H ). Importantly, Nrf2 was found to be a regulator of the PPP in cancer cells (Mitsuishi et al., 2012) and analyzing expression data from Nrf2-deficient macrophages (GEO: GSE71695) revealed that several PPP genes, including Pgd, are downregulated in Nrf2-deficient macrophages (Figure S4E) . Moreover, analysis of published chromatin immunoprecipitation (ChIP-seq) data (DDBJ: DRA003771) revealed binding of Nrf2 4 kb upstream of the Pgd locus ( Figure 3I ), suggesting a direct link between reduced Nrf2 activity and Pgd expression in HFD macrophages. Indeed, Pgd is suppressed in Nrf2-deficient macrophages and increased in macrophages that have lower levels of the Nrf2 repressor protein KEAP1 ( Figure 3J ). Accordingly, the LPS-induced production of sedoheptulose-7P and ribose-5P or ribulose-5P downstream of Pgd in the PPP was blunted in the absence of Nrf2 ( Figure S4F ). This suppressed Nrf2 signaling acts in parallel with other pathways, like the LXR pathway (Spann et al., 2012) , and manipulating one branch does not recapitulate the deactivated phenotype observed in HFD macrophages. Indeed, Nrf2-deficient macrophages did not show overall suppressed LPS responses ( Figure S4G ).
Together, this demonstrates a link between reduced Nrf2 and a defective PPP in HFD macrophages and that the latter pathway supports inflammatory responses. Figures S3A and S3B ). (B) Cytokine and NO production by NFD and HFD macrophages (see also Figure S3C ). (C) Reactive oxygen species (ROS) levels as measured with 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H 2 DCFDA). (D) Phagocytic capacity (see also Figure S3E ). (E) Real-time ECAR of NFD and HFD macrophages. The bar graph represents the acute LPS-induced ECAR. (F) Glycolysis parameters were determined by recording the ECAR after injection of glucose, OM, and 2-deoxyglucose (2-DG). The glycolytic rate is plotted in a bar graph (glucose uptake in Figure S3D Leukocytes from FH patients demonstrated reduced expression of genes related to OXPHOS. In mice, hypercholesterolemia was associated with reduced cholesterol biosynthesis in macrophages. Differences in cell type (total leukocytes versus macrophages) or species (human versus mouse) might underlie this discrepancy. Dhcr24, which encodes 24-dehydrocholesterol reductase, which converts desmosterol into cholesterol, was the most suppressed gene related to cholesterol biosynthesis in macrophages from HFD mice. This finding is in agreement with a previous study, and diminished Dhcr24 expression was found to result in the accumulation of desmosterol in HFD macrophages (Spann et al., 2012) .
Isolated macrophages from hypercholesterolemic mice showed reduced maximal respiration and SRC. In T cells, SRC is positively correlated with their survival (van der Windt et al., 2012). Therefore, decreased SRC might increase the susceptibly to apoptosis in macrophage foam cells, potentially contributing to necrotic core development in atherosclerotic lesions (Moore et al., 2013) .
It is well-accepted that atherosclerosis is a chronic inflammatory disease driven by elevated LDL cholesterol levels. The Canakinumab Antiinflammatory Thrombosis Outcome Study (CANTOS) trial provides strong evidence in support of the inflammation hypothesis and demonstrated that neutralizing the proinflammatory cytokine IL-1b significantly reduces the rate of recurrent cardiovascular events (Ridker et al., 2017) .
Confirming previous literature (Spann et al., 2012) , we now observed that the LPS-induced secretion of inflammatory mediators was reduced in macrophages isolated from hypercholesterolemic mice. This might appear to be inconsistent with the inflammation hypothesis of atherogenesis. However, it is important to note that both in vivo-elicited HFD foam cells and in vitro LDL-exposed macrophages still produce considerable amounts of inflammatory cytokines upon activation, albeit to a lower extend than ''normal'' macrophages. Another explanation for the observed deactivated phenotype of foam cells could be the phenotypic diversity detected in plaques (Cochain et al., 2018) . Not all plaque macrophages exhibit a pro-inflammatory phenotype, and there is a substantial subpopulation of macrophages with anti-inflammatory features (Kadl et al., 2010) . In agreement with our observations, recent transcriptome analysis of macrophages from atherosclerotic aortae revealed that lipid-loaded plaque macrophages are less inflammatory than their non-foamy counterparts . We therefore favor the theory that, in addition to the systemic metabolic environment, microenvironmental cues regulate macrophage phenotypes in plaques (Spann et al., 2012) to promote the chronic inflammatory responses that are demonstrably driving atherogenesis.
Accumulation of cellular cholesterol leads to specific oxysterols and sterols that regulate the activity of LXR (Spann et al., 2012) . LXRs bind to and prevent the removal of repressor complexes at TLR4-responsive genes, blunting their expression and exerting anti-inflammatory effects (Ghisletti et al., 2007) . We now show that, in addition to LXR (Spann et al., 2012) , LXR-independent impairment of the PPP contributes to the suppressed inflammatory responses in macrophage foam cells during hypercholesterolemia.
Interestingly, we discovered that 6-phosphogluconate dehydrogenase (Pgd) gene expression and downstream metabolites were blunted in HFD macrophages. In accordance, knockdown of PGD was found to reduce the oxidative PPP flux, NADPH:NADP + ratio, and ribulose-5P and ribose-5P levels in human cancer cells (Lin et al., 2015) . NADPH and ribose-5P generated in the PPP can support the inflammatory macrophage responses in different ways, including ROS production, anti-oxidant cellular defense, fatty acid synthesis, and nucleotide production (Nagy and Haschemi, 2015) . Thus, reduced flux through the PPP as observed in HFD macrophages can cause attenuated inflammatory responses and ROS production. Furthermore, Pgd expression was already reduced in naive HFD macrophages, possibly creating a condition that causes impaired future LPS responses. Vice versa, the lower PPP might also be a consequence of an attenuated inflammatory phenotype in HFD macrophages and the consecutive lower demand for PPP-derived products that regulate inflammation and anti-oxidant cellular defense.
We identified the Nrf2-mediated oxidative stress response as the most suppressed pathway in LPS-stimulated HFD macrophages. Nrf2 emerged as a crucial regulator of the inflammatory responses in macrophages (Kobayashi et al., 2016; Mills et al., 2018) . Interestingly, several PPP genes were previously identified as Nrf2 target genes in cancer cells (Mitsuishi et al., 2012) . Here we emphasized the importance of the Nrf2 pathway in the regulation of the PPP in macrophages. Importantly, suppressed Nrf2 is not the only mediator of the HFD macrophage phenotype and probably acts in parallel with other mechanisms, like the desmosterol-induced LXR pathway that was described earlier (Spann et al., 2012) . Indeed, LXR activation or Nrf2 deletion as such did not result in the deactivated HFD macrophage phenotype. Our observations agree with previous studies demonstrating normal IL-1b, TNF, and IL-6 expression in the absence of Nrf2 Bambouskova et al., 2018; Kobayashi et al., 2016) . Conversely, activation of Nrf2 in macrophages by pharmacological or genetic (low KEAP1 expression) means clearly dampens inflammatory responses (Kobayashi et al., 2016) and mediates the anti-inflammatory effects of the metabolite itaconate . Thus, low levels of Nrf2 do not affect LPS responses as such, but Nrf2 activation is clearly anti-inflammatory. It will be of interest to define the mechanism responsible for Nrf2 repression in macrophage foam cells.
Together, these observations show that hypercholesterolemia suppresses the Nrf2 and PPP in macrophages and deactivates their inflammatory phenotype. We demonstrate that systemic Figures S4A and S4E-S4G ).
Values represent mean ± SEM of three (C, E, and J) or four mice (A). One-way ANOVA; *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant. metabolic changes translate into rewired intracellular metabolic pathways in macrophages that are tailored to support their effector functions. This highlights the intricate interplay between inflammatory signaling and metabolic pathways.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: CVON 2011-19 and CVON 2017-20) and Cancer Research UK (C20953/A18644). We thank Tadeja Rezen, Peter Juvan, and Damjana Rozman for the GEO: GSE13985 dataset details. 
AUTHOR CONTRIBUTIONS
Conceptualization
DECLARATION OF INTERESTS
The authors declare no competing interests. 
METHOD DETAILS
Isolation of macrophages After 10 weeks of NFD or HFD, Lldr KO mice were euthanized by CO 2 asphyxiation. Four days prior to sacrifice, mice were intraperitoneally injected with 3% thioglycollate medium (Fisher Scientific). Upon sacrifice, the peritoneum was flushed with 10 mL ice-cold PBS and collected peritoneal cells were cultured in RPMI-1640 containing 25 mM HEPES, 2 mM L-glutamine, 10% FCS, 100 U/ml penicillin and 100 mg/ml streptomycin (GIBCO). After 3 h, non-adherent cells were washed away and adhered cells (typically consisting of 90%-95% CD11b + F4/80 + macrophages, Figure S1D ) were stimulated for 24 hours with 10 ng/ml LPS (Sigma) or 100 U/ml IL-4 (Peprotech), or were left untreated, and were used for further analyses. Blood cholesterol and triglyceride levels were measured by enzymatic methods using available kits (Roche). To determine lipid accumulated in peritoneal macrophages, tissue slides with cells were fixed in 4% formalin for 10 minutes and washed two times with PBS (with magnesium and chloride) before and after fixation. Subsequently, tissue slides were incubated in 60% isopropanol for 15 minutes before staining for 45 minutes with fresh 0.3% Oil Red O in 60% isopropanol. After staining, tissue slides were rinsed in 60% isopropanol, washed in distilled water, incubated for 1 minute with hematoxylin blued in tap water and rinsed with distilled water. Bone-marrow derived (BMDM) macrophages were generated from femurs and tibia from WT, Nrf2 KO and Keap1 KD mice and differentiated in RPMI-1640 containing 25 mM HEPES, 2 mM L-glutamine, 10% FCS, 100 U/ml penicillin and 100 mg/ml streptomycin and 15% L929-conditioned medium for 7 days.
Metabolic extracellular flux analysis Macrophages (1x10 5 cells/well) were plated on XF-96-cell culture plates (Seahorse Bioscience) and treated as specified. OCR and ECAR were assessed using the XF-96 Flux Analyzer (Seahorse Bioscience) as detailed before (Van den Bossche et al., 2015) . Changes in ECAR in response to glucose (10 mM), OM (1.5 mM) and 2-DG (100 mM) injection were used to calculate all glycolysis parameters and OXPHOS characteristics were calculated from the OCR changes in response to OM (1.5 mM), FCCP (1.5 mM) and rotenone (1.25 mM) + antimycin A (2.5 mM) injection (Van den Bossche et al., 2015; Van den Bossche et al., 2016) . The Seahorse Bioscience Mito Fuel Flex Test Kit was used to determine the dependency of cells for glucose, glutamine or fatty acid oxidation.
Respiratory measurements of isolated mitochondria
To isolate mitochondria, cell pellets were resuspended in 1 mL of MTE buffer (250 mM mannitol, 5 mM TRIS, 0.5 mM EDTA, pH 7.4). Macrophages were lysed using 10 passages through the cell cracker (European Molecular Biology Laboratory, Heidelberg, Germany). The homogenate was centrifuged 10 min at 1000 g, after which the supernatant was transferred to a new tube and centrifuged at 10000 g. The resulting supernatant was considered the cytosolic fraction. The final pellet containing the mitochondrial fraction was washed with 1 mL MTE buffer, centrifuged at 3600 g and resuspended in a minimal volume of MTE buffer. Equal amounts of mitochondria (0.5 mg well) were resuspended in MAS buffer (70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, and 1 mM EGTA; pH 7.2, plus 10 mM pyruvate and 1 mM malate as substrates), transferred to XF-96-cell culture plates, centrifuged at 2000 g for 20 min at 4 C and measured using a XF-96 Flux Analyzer (Seahorse Bioscience) to assess basal oxygen consumption (state 2), maximal coupled respiration or state 3 after injection of 4 mM ADP, state 4o after injection of 1.5 mM OM, maximal uncoupled respiration (state 3u) after injection of 4 mM FCCP and the respiratory control ratio (RCR = state 3/state 4o) in accordance to an established protocol (Rogers et al., 2011) . D 3 -glutamate, 13 C 3 -pyruvate, 13 C 6 -isoleucine, 13 C 6 -glucose, 13 C 6 -fructose-1,6-biphosphate, 13 C 6 -glucose-6-phosphate, adenosine-15 N 5 -monophosphate and guanosine-15 N 5 -monophosphate (5 mM). 1 mL of chloroform was added, vortexed and centrifuged
